Literature DB >> 1087116

Identification of T cell lymphoma tumor antigens on human T cell lines.

J Kaplan, J Tilton, W D Peterson.   

Abstract

All human T lymphoblast cell lines have been derived from subjects with leukemia secondary to thymic lymphoblastic lymphoma, a T cell malignancy, suggesting that such lines represent established cultures of neoplastic T cells. Based on this observation, we prepared rabbit antisera to T cell line HSB-2, removed reactivity for histocompatibility antigens and normal T cells by absorption with autocthonous B cell line CCRF-SB and normal thymocytes, and tested the absorbed antisera by complement-dependent cytotoxicity against a panel of normal and malignant cells. A representative antiserum reacted with all 4 T cell lines (mean cytotoxic index =56) and with tumor cells from 4 patients with T cell lymphoma (mean cytotoxic index = 50) but did not react with tumor cells from 6 patients with other types of leukemias (mean cytotoxic index = 2), with 3 B cell lines (mean cytotoxic index = 1), normal peripheral blood lymphocytes (mean cytotoxic index = 5), or normal thymocytes (mean cytotoxic index = 6). We conclude that appropriately absorbed antisera to human T cell lines detect T cell lymphoma tumor antigens.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1087116     DOI: 10.1002/ajh.2830010206

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  20 in total

1.  The interleukin 2 gene is expressed in the syncytiotrophoblast of the human placenta.

Authors:  K D Boehm; M F Kelley; J Ilan; J Ilan
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

2.  Electroporation: application to human lymphoid cell lines for stable introduction of a transactivator gene of human T-cell leukemia virus type I.

Authors:  K Ohtani; M Nakamura; S Saito; K Nagata; K Sugamura; Y Hinuma
Journal:  Nucleic Acids Res       Date:  1989-02-25       Impact factor: 16.971

3.  Functional mapping of the activity of the R region in the human T-cell leukemia virus type I long terminal repeat to increase gene expression.

Authors:  M Nakamura; K Ohtani; Y Hinuma; K Sugamura
Journal:  Virus Genes       Date:  1989-03       Impact factor: 2.332

4.  Human T-cell leukemia virus-associated membrane antigens: identity of the major antigens recognized after virus infection.

Authors:  T H Lee; J E Coligan; T Homma; M F McLane; N Tachibana; M Essex
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

5.  Structural characterization of SIL, a gene frequently disrupted in T-cell acute lymphoblastic leukemia.

Authors:  P D Aplan; D P Lombardi; I R Kirsch
Journal:  Mol Cell Biol       Date:  1991-11       Impact factor: 4.272

6.  Abundant transcription of a cellular gene in T cells infected with human T-cell leukemia-lymphoma virus.

Authors:  V Manzari; R C Gallo; G Franchini; E Westin; L Ceccherini-Nelli; M Popovic; F Wong-Staal
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

7.  p21X mRNA is expressed as a singly spliced pX transcript from defective provirus genomes having a partial deletion of the pol-env region in human T-cell leukemia virus type 1-infected cells.

Authors:  S Orita; H Kobayashi; Y Aono; A Saiga; M Maeda; H Igarashi
Journal:  Nucleic Acids Res       Date:  1993-08-11       Impact factor: 16.971

8.  Transcriptional initiation and postinitiation effects of murine leukemia virus long terminal repeat R-region sequences.

Authors:  L A Cupelli; J Lenz
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

9.  Selective regulation of intercellular adhesion molecule-1 expression by interleukin-18 and interleukin-12 on human monocytes.

Authors:  Rogier J L Stuyt; Mihai G Netea; Teunis B H Geijtenbeek; Bart Jan Kullberg; Charles A Dinarello; Jos W M van der Meer
Journal:  Immunology       Date:  2003-11       Impact factor: 7.397

10.  Purification and partial sequence analysis of human T-cell growth factor.

Authors:  R J Robb; R M Kutny; V Chowdhry
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.